Skip to main content
. 2014 May 14;20(18):5435–5441. doi: 10.3748/wjg.v20.i18.5435

Table 1.

Possible risk markers for liver injury

ORF Major Mutations Clinical status Ref.
PreS1/S2/S
preS deletion CHB [49-51]
FHB [52,53]
AHB [54,55]
HCC [56-61,78]
Occult infection [62]
W4P/R male predominace HCC and LC [23]
S
T207A LC [63]
T770C HCC GenBank no.AY206393
C695 Occult infection [64]
T207A HBsAg(-) [65-67]
X
A1762T/G1764A LC,HCC [68,69,71,75-79]
mild liver histology [72]
C1653T LC,HCC [75,77-79]
T1753V LC,HCC [75,77-80]
G1386M LC,HCC
B1499 LC,HCC [75]
G1613A LC,HCC [77,79]
A1727G LC,HCC [76,77]
G1757A LC,HCC [76,77]
C1766T LC,HCC [76-78]
T1768A LC,HCC [77,78]
A1727G HCC [76]
C1773T HCC [76]
preC/C
A1896T FHB,HCC [37,80]
G1899A HCC [37]
C1913A or C1914T HCC [37]
A2149C/T HCC [37]
A2188T/C HCC [37]
C2198A HCC [37]
C2444A/T HCC [37]
core antigen internal deletions CHB [82,83]
HCC [84]
immune-suppressed patients [85]
P
G741H HCC [89,93]
CHB [90-93]

ORF: Opening reading frame; HCC: Hepatocellular carcinoma; CHB: Chronic hepatitis B; FHB: Fulminant hepatitis B; AHB: Acute hepatitis B; LC: Liver cirrhosis.